Cargando…
Pulmonary mucormycosis associated with medical marijuana use
A 66-year-old man with diabetes presented to the hospital with a two-month history of dyspnea, cough, rust-colored sputum, night sweats and 20 pound weight loss. He had begun smoking medical marijuana 3 months earlier. CT of the chest showed multiple bilateral large ground glass opacities with surro...
Autores principales: | Stone, Taylor, Henkle, Joseph, Prakash, Vidhya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330507/ https://www.ncbi.nlm.nih.gov/pubmed/30671341 http://dx.doi.org/10.1016/j.rmcr.2019.01.008 |
Ejemplares similares
-
Critical COVID-19-associated pulmonary mucormycosis: The underreported life-threatening spectrum of the mucormycosis epidemic
por: Mehta, Ravindra M, et al.
Publicado: (2022) -
Pulmonary Mucormycosis: An Emerging Infection
por: Muqeetadnan, Mohammed, et al.
Publicado: (2012) -
Medical marijuana utilization in gynecologic cancer patients
por: Fehniger, Julia, et al.
Publicado: (2021) -
Medical marijuana for the treatment of vismodegib-related muscle spasm
por: Yuan, Joyce T., et al.
Publicado: (2017) -
Mucormycosis causing pulmonary artery aneurysm
por: Ramachandran, Lakshman, et al.
Publicado: (2015)